Phosphate Transporters Expression in Patients with Primary Familial Brain Calcifications

Area of Science:

• Neurology
• Genetics
• Biochemistry

Background:

• Primary familial brain calcification (PFBC), or Fahr disease, is a rare neurological disorder.
• PFBC involves extensive calcification deposits within the brain.
• Genetic variations in SLC20A2, PDGFβ, PDGFRβ, and XPR1 are associated with PFBC.

Purpose of the Study:

• To investigate the expression levels of inorganic phosphate (Pi) transporters SLC20A1, SLC20A2, and XPR1 in PFBC patients.
• To determine if altered Pi transporter expression correlates with PFBC mutations.

Main Methods:

• Real-time quantitative PCR (qPCR) was employed to analyze gene expression.
• Expression levels of SLC20A1, SLC20A2, and XPR1 were measured in blood samples from PFBC patients and controls.

Main Results:

• A significant reduction of approximately 40% in SLC20A2 gene expression was observed in PFBC patients with known mutations.
• No significant changes in SLC20A2 expression were found in PFBC patients without identified mutations.
• Expression levels of SLC20A1 and XPR1 remained unchanged across all patient groups and controls.

Conclusions:

• Mutations in the SLC20A2 gene play a crucial role in PFBC by directly reducing its expression in patient blood.
• The study did not find evidence of co-regulation of SLC20A1, SLC20A2, and XPR1 at the mRNA level in PFBC patients.